Innovative Molecules

Developer of drugs to treat Herpes simplex-induced diseases

placeMunich, Bavaria, Germany calendar_todayFounded 2003 language innovativemolecules.com

Registered entities

Investor mix

2 investors on record; lead investors include Life Sciences Partners.

Investor typeCountShare
Private equity2100%
Coming soon